BioNexus Gene Lab Corp. Tax Withholding Paid on Stock Awards
BioNexus Gene Lab Corp. (BGLC) reported Tax Withholding Paid on Stock Awards of $141.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2025-04-15
- BioNexus Gene Lab Corp. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $141.00K, a 72.45% decline from fiscal 2023.
- BioNexus Gene Lab Corp. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $511.74K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|
| 2024-12-31 | $141.00K 10-K · filed 2025-04-15 |
| 2023-12-31 | $511.74K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |